Virus News and Research

Latest Virus News and Research

Researchers develop promising recombinant flu vaccine using nanoliposome technology

Recombinant protein vaccines, like the Novavax vaccine used to fight COVID-19, offer several advantages over conventional vaccines.

24 Feb 2024

Innovative research identifies key genes in cassava whitefly management

Whiteflies, particularly the African cassava whitefly (Bemisia tabaci, SSA1-SG1), pose a significant threat to agricultural productivity in Sub-Saharan Africa by transmitting viruses that cause cassava brown streak disease and cassava mosaic virus disease.

23 Feb 2024

Understanding the role played by HIV in pulmonary hypertension

Across the globe, more than 39 million people are living with the Human Immunodeficiency Virus (HIV), the virus that causes AIDS, including more than 1.3 million new HIV diagnoses last year.

23 Feb 2024

Gut microbial metabolite plays a role in exacerbating thrombosis

A gut microbial metabolite called 2-methylbutyrylcarnitine (2MBC) plays a role in exacerbating thrombosis -- the formation of blood clots – researchers report February 23rd in the journal Cell Metabolism.

23 Feb 2024

Yale School of Medicine secures $575,000 grant for Long COVID research

Yale School of Medicine and its Center for Infection & Immunity (CII) are receiving a $575,000 grant from PolyBio Research Foundation to fund Long COVID research.

23 Feb 2024

Research reveals bacteria's dynamic defense duo against phage viruses

Scientists at the University of Southampton have discovered that bacteria can pair up their defense systems to create a formidable force, greater than the sum of its parts, to fight off attack from phage viruses.

23 Feb 2024

Researchers identify potential treatment for cardiovascular disease linked to Type 2 diabetes

New research at the Roy Blunt NextGen Precision Health building has discovered a potential treatment for an underlying cause of cardiovascular disease in people with Type 2 diabetes.

23 Feb 2024

Increased paxlovid use could lead to significant hospitalization reductions and cost savings

Increased use of Paxlovid, the antiviral drug used to treat COVID-19, could prevent hundreds of thousands of hospitalizations and save tens of billions of dollars a year, according to a new epidemiological model published by researchers at The University of Texas at Austin.

23 Feb 2024

Florida defies CDC in measles outbreak, telling parents it’s fine to send unvaccinated kids to school

With a brief memo, Florida Surgeon General Joseph Ladapo has subverted a public health standard that's long kept measles outbreaks under control.

23 Feb 2024

Developing a novel norovirus vaccine candidate with INTEGRA pipettes

INTEGRA Biosciences has awarded 50 EVOLVE manual pipettes, GRIPTIPS® pipette tips worth US $1000 and various lab accessories to HilleVax, helping to advance its pioneering research into norovirus vaccine development.

From INTEGRA Biosciences 23 Feb 2024

Natural killer cells lead the charge in cancer treatment innovation

Review synthesizes research on NK cells' role in cancer immunity and their potential in therapeutics through bioengineering, immune checkpoint inhibitors, and cell engagers, highlighting ongoing preclinical and clinical trials.

22 Feb 2024

Persistent COVID-19 could drive virus evolution, new study suggests

Study reveals the prevalence of persistent SARS-CoV-2 infection in the UK, showing its potential role in viral evolution and the emergence of new variants, with implications for long-COVID and public health strategies.

22 Feb 2024

Major discovery improves the understanding of brain fog associated with Long COVID

Today, a team of scientists from Trinity College Dublin and investigators from FutureNeuro announced a major discovery that has profound importance for our understanding of brain fog and cognitive decline seen in some patients with Long COVID.

22 Feb 2024

October found to be the optimum time to vaccinate against influenza

The optimum time to vaccinate young infants against influenza.

22 Feb 2024

Scripps Research scientists develop an antibody that blocks lethal snake toxins

Scripps Research scientists have developed an antibody that can block the effects of lethal toxins in the venoms of a wide variety of snakes found throughout Africa, Asia and Australia.

21 Feb 2024

Study reveals high prevalence of persistent COVID-19 infections in general population

A new study led by the University of Oxford has found that a high proportion of SARS-CoV-2 infections in the general population lead to persistent infections lasting a month or more.

21 Feb 2024

IκBζ protein holds potential for treating autoimmune conditions

Our immune system is remarkably powerful. It quickly assembles teams of cells to eliminate threats inside our bodies.

21 Feb 2024

Breakthrough gene therapy method utilizes bird retrotransposon for safe gene insertion

The recent approval of a CRISPR-Cas9 therapy for sickle cell disease demonstrates that gene editing tools can do a superb job knocking out genes to cure hereditary disease.

20 Feb 2024

Researchers develop novel nanomedicine loaded with genetic material to fight HIV

Society learned about the value of mRNA during the COVID-19 pandemic when we saw scientists and medical professionals harness its power to deliver a vaccine for the virus within a year.

20 Feb 2024

Study suggests high levels of vitamin B3 breakdown products are linked to higher risk of mortality, heart attacks, and stroke

Researchers utilized an untargeted metabolomics technique to look for new compounds and pathways that may contribute to residual cardiovascular disease risk.

19 Feb 2024

Previous
1
...
52
53
54
55
56
57
58
...
1553
Next

Virus News and Research

Latest Virus News and Research

Researchers develop promising recombinant flu vaccine using nanoliposome technology

Innovative research identifies key genes in cassava whitefly management

Understanding the role played by HIV in pulmonary hypertension

Gut microbial metabolite plays a role in exacerbating thrombosis

Yale School of Medicine secures $575,000 grant for Long COVID research

Research reveals bacteria's dynamic defense duo against phage viruses

Researchers identify potential treatment for cardiovascular disease linked to Type 2 diabetes

Increased paxlovid use could lead to significant hospitalization reductions and cost savings

Florida defies CDC in measles outbreak, telling parents it’s fine to send unvaccinated kids to school

Developing a novel norovirus vaccine candidate with INTEGRA pipettes

Natural killer cells lead the charge in cancer treatment innovation

Persistent COVID-19 could drive virus evolution, new study suggests

Major discovery improves the understanding of brain fog associated with Long COVID

October found to be the optimum time to vaccinate against influenza

Scripps Research scientists develop an antibody that blocks lethal snake toxins

Study reveals high prevalence of persistent COVID-19 infections in general population

IκBζ protein holds potential for treating autoimmune conditions

Breakthrough gene therapy method utilizes bird retrotransposon for safe gene insertion

Researchers develop novel nanomedicine loaded with genetic material to fight HIV

Study suggests high levels of vitamin B3 breakdown products are linked to higher risk of mortality, heart attacks, and stroke

A new way of characterising biomolecules eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in